Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

ACC Ltd - Q1CY21 Result Update - YES Securities

Posted On: 2021-04-20 11:05:53 (Time Zone: UTC)


Result Highlights

- Volume dispatches for the quarter stood at 7.97 MT translating into 21.5% y/y growth vis--vis expected growth of 18.7% y/y. RMC volumes continue to recover with normalcy in construction activities across metro cities as volumes came in at 0.83 mcm (down by ~10% y/y and lowest de-growth over last 4 qtrs).

- Cement NSR/te was Rs 4,876 during the quarter witnessing a healthy improvement of 6.5% y/y (vs. est. of +3.5% y/y). Improvement and outperformance in NSR/te on y/y basis was primarily driven by product mix optimization and higher share of premium products.

- Net sales for the company stood at Rs 42.9 bn - a growth of 22.6% y/y and 0.5% above our estimates.

- ACC delivered extremely strong outperformance on EBITDA level with absolute EBITDA for the quarter at Rs 8.6 bn (+22% above our estimates and +20% above consensus estimates) while EBITDA growth stood at 47% y/y. Per ton profitability on blended basis came in at Rs 1,041 (vs. est. of Rs 870) translating into healthy improvement of 22% y/y and 18.4% q/q. Better pricing and lower clinker cost led to strong operational performance for the company.

- Net profit for the company stood at Rs 5.62 bn which grew by 74.2% y/y.

Our View:

- ACC delivered strong set of numbers for Q1CY21 with marginal outperformance on volumes (+21.5% y/y and +2.2% above estimates) and massive outperformance on EBITDA level (+47% y/y) which was 22% above our estimates and 20% above consensus estimates. Better than expected realizations due to higher share of premium products (cement NSR up 6.5% y/y vs est. of +3.5% y/y) and lower clinker cost led to beat on operating performance.

- Going ahead, on the back of sharp surge in energy prices (spot prices at ~Rs 1.4/kcal on blended basis vs consumption cost of Rs 1.1-1.2/kcal during the quarter), we expect P&F costs to rise by ~Rs 170/te sequentially from Q2CY21E onwards. However, strong pricing scenario and operating leverage would offset the surge in costs to some extent translating into range-bound profitability for CY21E vis--vis CY20.

- We upgrade our volume estimates by 4.8%/2.4% and EBITDA estimates by 12.1%/11.2% for CY21E/CY22E respectively.

- ACC is speedily ramping up recently commissioned 1.4 MTPA brownfield grinding unit in Jharkhand while company expects to commission Ametha project in Central market by Q2CY22.

- In the medium term, we expect volume/EBITDA CAGR of 13.5%/11.3% over CY20-CY22E. Balance sheet would continue to remain strong despite capex with net cash of Rs 65.4 bn in CY22E vs ~Rs 60 bn in CY20.

- At CMP of Rs 1,877, ACC is trading at EV/EBITDA of 9.5x on CY22E. We continue to assign EV/EBITDA multiple of 10x on CY22E and arrive at TP of Rs 2,028/share with potential upside of 8% (previous TP of Rs 1,845). We have an ADD rating on the stock.

- Key Risk: Further lockdowns across states due to second wave of COVID would hamper volume growth and timelines of capex commissioning.

Shares of ACC LTD. was last trading in BSE at Rs.1824.45 as compared to the previous close of Rs. 1876.85. The total number of shares traded during the day was 219560 in over 13479 trades.

The stock hit an intraday high of Rs. 1982 and intraday low of 1810. The net turnover during the day was Rs. 414358399.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.


Other Headlines:

Maintain BUY on Federal Bank - Pristine asset quality offsets a low provisioning buffer - HDFC Securities

YES SECURITIES on Colgate Palmolive 4QFY21 results - Growth still elusive but margins keep racing ahead

SELL recommendation on Vinati Organics - Robust quarter - HDFC Securities

Maintain ADD on Colgate Palmolive - Beat on all fronts; focus on new launches' success - HDFC Securities

Maintain BUY on Oberoi Realty - Blockbuster quarter - HDFC Securities

Just Dial - Q4FY21 Result Update - YES Securities

Colgate-Palmolive (India) Ltd - Q4FY21 Result Update - YES Securities

Gland Pharma - Q4FY21 Result Update - YES Securities

Oberoi Realty Ltd - Q4FY21 Result Update - YES Securities

Bharti Airtel - Q4 FY21 First cut: Inline - YES Securities

Colgate Palmolive (India) - More of the same - ICICI Securities

Federal Bank - Steady asset quality despite challenges - ICICI Securities

Rossari Biotech - Inorganic growth is key to watch - ICICI Securities

Garden Reach Shipbuilders & Engineers - Execution pickup expected in FY22E - ICICI Securities

Mindspace Business Parks REIT - Q4FY21 - Near-term weakness to persist - ICICI Securities

Oberoi Realty - New launches drive record sales bookings - ICICI Securities

Q4FY21 Company Update - Gokaldas Exports - ICICI Direct

Q4FY21 Result Update - Oberoi Realty - ICICI Direct

Q4FY21 Result Update - Federal Bank - ICICI Direct

Bharti Airtel - Q4FY21 First Cut - ICICI Direct

Maintain BUY on Cipla - Weak quarter, outlook promising - HDFC Securities

Maintain BUY on Larsen & Toubro - Growth returns - HDFC Securities

Escorts - Lowered demand guidance - HDFC Securities

Maintain ADD on Dr. Reddy's Labs - Sputnik V launch to lift near-term outlook - HDFC Securities

AU Small Finance Bank - Showcasing liability strength - cuts SA rate - ICICI Securities

Indigo Paints - The investments thesis is (nearly) intact - ICICI Securities

Greenpanel Industries - Strong growth momentum sustains - ICICI Securities

Aditya Birla Capital - Operating performance gathers momentum; company poised for RoE improvement - ICICI Securities

Dr. Reddy's Laboratories - Steady quarter; outlook intact - ICICI Securities

Cipla - Weak Q4; on track to sustain higher margins - ICICI Securities

Larsen & Toubro - Focus on margins and asset liquidation - ICICI Securities

Voltas - Q4FY21 Result Update - YES Securities

Mphasis - Q4FY21 Result Update - YES Securities

Dr Reddy's Laboratories - Q4FY21 Result Update - YES Securities

Sagar Cements Ltd - Q4FY21 Result Update - YES Securities

Greenpanel Industries Ltd - Q4FY21 Result Update - YES Securities

Larsen & Toubro Ltd - Q4FY21 Result Update - YES Securities

Balkrishna Industries - Growth momentum accelerates - ICICI Securities

Voltas - Healthy growth, uncertain outlook - ICICI Securities

Vedanta - Aluminium, Zinc India continue to drive earnings - ICICI Securities

Q4FY21 Result Update - SKF India - ICICI Direct

Q4FY21 Result Update - Sagar Cements - ICICI Direct

Q4FY21 Result Update - Dr Reddy's Laboratories - ICICI Direct

Q4FY21 Result Update - Dwarikesh Sugar - ICICI Direct

Q4FY21 Result Update - Indian Energy Exchange - ICICI Direct

Q4FY21 Result Update - Balkrishna Industries - ICICI Direct

Q4FY21 Result Update - Avadh Sugar & Energy - ICICI Direct

Q4FY21 Company Update - Vardhman Special Steel - ICICI Direct

Q4FY21 Result Update - Cipla Ltd - ICICI Direct

Q4FY21 Result Update - Larsen & Toubro - ICICI Direct


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020